Cargando…

Willingness to COVID-19 vaccination: Empirical evidence from EU

The unforgettable COVID-19 shock is most likely to be reversed by a viable vaccination strategy. In this paper, we investigate willingness to be vaccinated (WTV) against the COVID-19. Current trends suggest that only around 73% of EU inhabitants (15 and +) were immunized, with more than 104 million...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Imran Ur, Austin, Arslan, Nelson, Naveed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152756/
https://www.ncbi.nlm.nih.gov/pubmed/37153419
http://dx.doi.org/10.1016/j.heliyon.2023.e15776
_version_ 1785035803073708032
author Rahman, Imran Ur
Austin, Arslan
Nelson, Naveed
author_facet Rahman, Imran Ur
Austin, Arslan
Nelson, Naveed
author_sort Rahman, Imran Ur
collection PubMed
description The unforgettable COVID-19 shock is most likely to be reversed by a viable vaccination strategy. In this paper, we investigate willingness to be vaccinated (WTV) against the COVID-19. Current trends suggest that only around 73% of EU inhabitants (15 and +) were immunized, with more than 104 million people still warranted to be immunized. Vaccine reluctance is a key impediment to conducting immunization programs in the setting of a pandemic. We provide first of its kind empirical evidence on the citizens (N = 11,932) of the EU-27 by employing the recent data from the European Commission. Based on the survey responses, controlling for the correlations in the error terms, we utilize a simulated multivariate probit regression model. Our results show that amongst all the statistically significant drivers of the WTV, the positive perception (vaccination works and has no side effects); R&D information (clarity on how vaccination is developed, tested, authorized) has the largest impact on the WTV. We find that the group of variables on social feedback (Positive perception; social adoption and pressure), and on trustworthy sources of information (R&D info; medical advice) are to be considered for WTV policy. The counteracting policy gaps that act against WTV include vaccination governance dissatisfaction, perception of long-term side effects, growing mistrust in information sources, uncertainty between safety and efficacy, education level, and risky age group. Strategies based on the outcomes of this study are needed to address public acceptance and willingness to vaccinate during a pandemic. This research is novel and offers authorities in-depth insights into the challenges and solutions regarding the COVID-19 pandemic and thus to its end via stimulation of the WTV.
format Online
Article
Text
id pubmed-10152756
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101527562023-05-02 Willingness to COVID-19 vaccination: Empirical evidence from EU Rahman, Imran Ur Austin, Arslan Nelson, Naveed Heliyon Research Article The unforgettable COVID-19 shock is most likely to be reversed by a viable vaccination strategy. In this paper, we investigate willingness to be vaccinated (WTV) against the COVID-19. Current trends suggest that only around 73% of EU inhabitants (15 and +) were immunized, with more than 104 million people still warranted to be immunized. Vaccine reluctance is a key impediment to conducting immunization programs in the setting of a pandemic. We provide first of its kind empirical evidence on the citizens (N = 11,932) of the EU-27 by employing the recent data from the European Commission. Based on the survey responses, controlling for the correlations in the error terms, we utilize a simulated multivariate probit regression model. Our results show that amongst all the statistically significant drivers of the WTV, the positive perception (vaccination works and has no side effects); R&D information (clarity on how vaccination is developed, tested, authorized) has the largest impact on the WTV. We find that the group of variables on social feedback (Positive perception; social adoption and pressure), and on trustworthy sources of information (R&D info; medical advice) are to be considered for WTV policy. The counteracting policy gaps that act against WTV include vaccination governance dissatisfaction, perception of long-term side effects, growing mistrust in information sources, uncertainty between safety and efficacy, education level, and risky age group. Strategies based on the outcomes of this study are needed to address public acceptance and willingness to vaccinate during a pandemic. This research is novel and offers authorities in-depth insights into the challenges and solutions regarding the COVID-19 pandemic and thus to its end via stimulation of the WTV. Elsevier 2023-05-02 /pmc/articles/PMC10152756/ /pubmed/37153419 http://dx.doi.org/10.1016/j.heliyon.2023.e15776 Text en © 2023 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Rahman, Imran Ur
Austin, Arslan
Nelson, Naveed
Willingness to COVID-19 vaccination: Empirical evidence from EU
title Willingness to COVID-19 vaccination: Empirical evidence from EU
title_full Willingness to COVID-19 vaccination: Empirical evidence from EU
title_fullStr Willingness to COVID-19 vaccination: Empirical evidence from EU
title_full_unstemmed Willingness to COVID-19 vaccination: Empirical evidence from EU
title_short Willingness to COVID-19 vaccination: Empirical evidence from EU
title_sort willingness to covid-19 vaccination: empirical evidence from eu
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152756/
https://www.ncbi.nlm.nih.gov/pubmed/37153419
http://dx.doi.org/10.1016/j.heliyon.2023.e15776
work_keys_str_mv AT rahmanimranur willingnesstocovid19vaccinationempiricalevidencefromeu
AT austinarslan willingnesstocovid19vaccinationempiricalevidencefromeu
AT nelsonnaveed willingnesstocovid19vaccinationempiricalevidencefromeu